Moreover, exploration of mechanism-based cardioprotective strategies derived from this investigation may yield novel therapeutic approaches for preventing or ameliorating VEGF(R)i-induced cardiac dysfunction in cancer patients. This evidence concerns the gene VEGFA and cancer.